Skip to main content

Table 3 Comparison of CRS and HIPEC in the experimental and control groups

From: Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study

 

Experimental group (N = 8)

Control group (N = 88)

Median duration of hospital stay

15 days (range 2–38)

15 days (range 4–63)

Median length of surgery (min)

485 (339–617)

502.50 (122–992)

Median blood loss (mL)

750 (100–2500)

700 (100–7000)

Resected organs

Hemicolectomy

2/8

43/110

(Sub)total colectomy

0/8

10/110

Pelvic peritoneum

6/8

81/110

Splenectomy

3/8

31/110

Small bowel resection

4/8

26/110

Cholecystectomy

2/8

23/110

  1. CRS cytoreductive surgery, HIPEC hyperthermic intraperitoneal chemotherapy